Should soybean agglutinin purging be performed in breast cancer patients undergoing autologous stem cell transplantation?

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 20, Issue 4, 1997, Pages 419-423

  Ben Yosef, Rami ^a   Or, Reuven ^a   Naparstek, Ella ^a   Kapelushnik, Joseph ^a   Samuels, Simcha ^a   Slavin, Shimon ^a   Nagler, Arnon ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

Autologous stem cell transplantation; Breast cancer; High dose chemotherapy; Purging

Indexed keywords

SOYBEAN AGGLUTININ;

ADULT; AGED; ANALYTIC METHOD; ARTICLE; AUTOGRAFT; BONE MARROW PURGING; BREAST CANCER; CANCER STAGING; CELL SURVIVAL; CLINICAL ARTICLE; FEMALE; HEMATOPOIETIC CELL; HIGH RISK POPULATION; HUMAN; RETROSPECTIVE STUDY; STEM CELL TRANSPLANTATION;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE MARROW PURGING; BREAST NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LECTINS; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PLANT LECTINS; REMISSION INDUCTION; RETROSPECTIVE STUDIES; SOYBEAN PROTEINS; SOYBEANS; SURVIVAL RATE; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, AUTOLOGOUS; TREATMENT OUTCOME;

EID: 0030791612     PISSN: 02773732     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000421-199708000-00021     Document Type: Article

References (24)

1. Bezwoda W, Seymour L, Dansey R. High-dose chemotherapy with hematopoietic rescue as primary treatment for metastatic breast cancer: a randomized trial. J Clin Oncol 1995;13(10): 2483-9.
2. Peters W, Berry D, Vredenburgh J, et al. Five-year follow-up of high-dose combination alkylating agents with ABMT as consolidation after standard-dose CAF for primary breast cancer involving >10 axillary lymph nodes (Duke CALGB 8782). ASCO Proceedings 1995:933 [Abstract].
3. Diel IJ, Kaufmann M, Goerner R, Costa SD, Kaul S, Bastert G. Detection of tumor cells in bone marrow of patients with primary breast cancer: a prognostic factor for distant metastasis. J Clin Oncol 1992;10:1534-9.
4. Cote RJ, Rosen PP, Lesser ML, Old LJ, Osborne MP. Prediction of early relapse in patients with operable breast cancer by detection of occult bone marrow micrometastases. J Clin Oncol 1991;9:1749-56.
5. Ross AA, Cooper B, Lazarus H, et al. Detection and viability of tumor cells in peripheral blood stem cell collections from breast cancer patients using immunocytochemical and clonogenic assay techniques. Blood 1993;82:2605-10.
6. Fields K, Elfenbein G, Moscinski L, Trudeau W, Janssen W. PCR detection of breast cancer cells in peripheral blood stem cell collections: incidence and correlations. Blood 1995;86: 2484 [Abstract].
7. Schulze R, Schulze M, Wischnik A, et al. Tumor cell contamination of peripheral blood stem cell transplants (PBSCT) and/ or bone marrow (BM) in high risk breast cancer patients (N ≥ 10). Blood 1995;86:923 [Abstract].
8. Landys K, Persson S, Kovarik J, Hultborn R, Holmberg E. Prognostic value of bone marrow biopsy in operable breast cancer patients at the time of initial diagnosis: results of a 19-year median follow-up. Eur J Cancer 1995;31 A(Suppl 5):647 [Abstract].
9. Mansi J, Berger U, McDonnell T, et al. The fate of bone marrow micrometastases in patients with primary breast cancer. J Clin Oncol 1989;7:445-9.
10. Sharp J, Kessinger A, Vaughan W, et al. Detection and clinical significance of minimal tumor contamination of peripheral blood stem cell harvests. J Cell Cloning 1992;10(Suppl 1):92-4.
11. Ybanez J, Lazarus H, Ross A, Cooper B. Impact of occult tumor (OT) reinfusion on outcome after high dose chemotherapy (HDC) in patients with advanced breast cancer. Blood 1995;86: 1532 [Abstract].
12. Shpall EJ, Cagnoni P, Gehling U, Hami LS, Hogan CJ. Bone marrow purging. In: Armitage J, Antman K, eds. High-dose cancer therapy, vol. 2. Baltimore: Williams & Wilkins, 1995: 289-318.
13. Morecki S, Pavlotzky F, Margel S, Slavin S. Purging breast cancer cells in preparation for autologous bone marrow transplantation. Bone Marrow Transplantation 1987;1:357-63.
14. Reisner Y, Gan J. Differential binding of soybean agglutinin to human neuroblastoma cell line: potential application to autologous bone marrow transplantation. Cancer Res 1985;45: 4026-31.
15. Mumcuoglu M, Favrot M, Slavin S. Lectin binding properties of Burkitt's lymphoma cell lines: application to bone marrow purging. Exp Hematol 1990;18:55-60.
16. Nagler A, Peacock M, Tantoco M, Lamons D, Okama TB, Okrongly DA. Red blood cell depletion and enrichment of CD34+ hematopoietic cells from human umbilical cord using soybean agglutinin and CD34+ immunoselection. Exp Hematol 1994;22:1134-40.
17. Morecki S, Margel S, Slavin S. Removal of breast cancer cells by soybean agglutination in an experimental model for purging human marrow. Cancer Res 1988;48:4573-7.
18. Kapelushnik J, Nagler A, Or R, et al. Autologous bone marrow transplantation for stage IV neuroblastoma: the role of soybean agglutinin purging. Transplant Proc 1993;25:975-6.
19. Ayash L, Wheeler C, Fairclough D, et al. Prognostic factors for prolonged progression-free survival with high-dose chemotherapy with autologous stem-cell support for advanced breast cancer. J Clin Oncol 1995;13:2043-9.
20. Shpall E, Jones R, Bast R. 4-HC purging of breast cancer from the mononuclear cell fraction of bone marrow in patients receiving high-dose chemotherapy and autologous marrow support: a phase I trial. J Clin Oncol 1991;9:85-93.
21. Coombes R, Buckman R, A. F. In vitro and in vivo effects of a monoclonal-antibody-toxin conjugate for patients with breast cancer. Cancer Res 1986;50:1170-5.
22. Lebkowski JS, Schain LR, Okrongly D, Levinsky R, Harvey MJ, Okarma TB. Rapid isolation of human CD34 hematopoietic stem cells-purging of human tumor cells. Transplantation 1992;53:1011-9.
23. Mapara MY, Korner IJ, Hildebrandt M, Bargou R, Dorken B. Immunomagnetic enrichment of CD34+ peripheral blood progenitor cells in breast cancer patients: monitoring of purging efficiency by cytokeratin 19 and EGF-R based RT-PCR. Blood 1995;86:922 [abstract].
24. Thomas TE, Zant GV, Phillips GL, Lansdorp PM. Simultaneous direct purging of breast carcinoma cells and enrichment of CD34+ cells using one step high gradient magnetic cell depletion. Blood 1995;86:2485 [abstract].